Related references
Note: Only part of the references are listed.The ability of atropine to prevent and reverse the negative chronotropic effect of fingolimod in healthy subjects
John M. Kovarik et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2008)
CYP4F enzymes are the major enzymes in human liver microsomes that catalyze the O-demethylation of the antiparasitic prodrug DB289 [2,5-bis(4-amidinophenyl)furan-bis-O-methylamidoxime]
Michael Zhuo Wang et al.
DRUG METABOLISM AND DISPOSITION (2006)
Oral fingolimod (FTY720) for relapsing multiple sclerosis
Ludwig Kappos et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
FTY720: Placebo-controlled study of the effect on cardiac rate and rhythm in healthy subjects
Robert Schmouder et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2006)
Overview of FTY720 clinical pharmacokinetics and pharmacology
JM Kovarik et al.
THERAPEUTIC DRUG MONITORING (2004)
Highly selective inhibition of human CYP3A in vitro by azamulin and evidence that inhibition is irreversible
DM Stresser et al.
DRUG METABOLISM AND DISPOSITION (2004)
FTY720 and cyclosporine:: Evaluation for a pharmacokinetic interaction
JM Kovarik et al.
ANNALS OF PHARMACOTHERAPY (2004)
FTY720: targeting G-protein-coupled receptors for sphingosine 1-phosphate in transplantation and autoimmunity
V Brinkmann et al.
CURRENT OPINION IN IMMUNOLOGY (2002)
Summary of information on human CYP enzymes: Human P450 metabolism data
S Rendic
DRUG METABOLISM REVIEWS (2002)
Share Paper
